Companies /Healthcare

Cue Biopharma

NASDAQ: CUE Biotechnology
$26.96
▼ $1.48 (−5.20%) today
Markets closed · 6:58pm ET
Today · % change

Fundamentals

Market Cap
$206.6M
Revenue (TTM)
$37.7M
EPS (TTM)
$-29.46
52-Week Range
$5 – $46
Street Target
$90.50

About Cue Biopharma

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biological drugs for the selective modulation of the human immune system to treat a variety of cancers, chronic infectious diseases, and autoimmune disorders. The company is headquartered in Cambridge, Massachusetts.

CUE Coverage